Cargando…

Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer

Despite the steadily increasing worldwide incidence of colorectal cancer (CRC), an effective noninvasive approach for early detection of CRC is still under investigation. The guaiac-based fecal occult blood test (FOBT) and fecal immunochemical test (FIT) have gained popularity as noninvasive CRC scr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Wei-Chih, Kao, Wei-Yu, Chang, Tsung-Kun, Tsai, Hsiang-Lin, Huang, Ching-Wen, Chen, Yen-Cheng, Li, Ching-Chun, Hsieh, Yi-Chien, Yeh, Hsing-Jung, Chang, Chun-Chao, Wang, Jaw-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2021
Materias:	Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809545/ https://www.ncbi.nlm.nih.gov/pubmed/33393623 http://dx.doi.org/10.1042/BSR20201930

Ejemplares similares

Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA
por: Han, Yoon Dae, et al.
Publicado: (2019)

A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA
por: Ma, Liang, et al.
Publicado: (2022)

Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer
por: Oh, Tae Jeong, et al.
Publicado: (2017)

SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer
por: Zhang, Weisong, et al.
Publicado: (2021)

SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer [Corrigendum]
Publicado: (2022)

Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial
por: Kim, Chang Woo, et al.
Publicado: (2021)

Suppression of oral cancer by induction of cell cycle arrest and apoptosis using Juniperus communis extract
por: Lee, Ching-Chang, et al.
Publicado: (2020)

Aberrant DNA Methylation of SEPT9 and SDC2 in Stool Specimens as an Integrated Biomarker for Colorectal Cancer Early Detection
por: Zhao, Guodong, et al.
Publicado: (2020)

Time interval between the completion of radiotherapy and robotic-assisted surgery among patients with stage I–III rectal cancer undergoing preoperative chemoradiotherapy
por: Huang, Ching-Wen, et al.
Publicado: (2020)

Oncological Outcomes of Robotic-Assisted Surgery With High Dissection and Selective Ligation Technique for Sigmoid Colon and Rectal Cancer
por: Yin, Tzu-Chieh, et al.
Publicado: (2020)

Clinical Outcomes of Metastatic Breast Cancer in Patients Having Imaging Liver Pseudocirrhosis with or without Evident Varices
por: Ma, Wei-Li, et al.
Publicado: (2022)

Methylated SFRP2 and SDC2 in stool specimens for Colorectal Cancer early detection: A cost-effective strategy for Chinese population
por: Zhao, Guodong, et al.
Publicado: (2021)

Unknown‑primary neuroendocrine neoplasms diagnosed by short‑acting somatostatin test: Case series in one institution
por: Chang, Tsung-Kun, et al.
Publicado: (2022)

Effects of the number of neoadjuvant therapy cycles on clinical outcomes, safety, and survival in patients with metastatic colorectal cancer undergoing metastasectomy
por: YEH, YUNG-SUNG, et al.
Publicado: (2023)

Solid Oxide Fuel Cells with Magnetron Sputtered Single-Layer SDC and Multilayer SDC/YSZ/SDC Electrolytes
por: Solovyev, Andrey, et al.
Publicado: (2023)

Impact of previous abdominal surgery on robotic-assisted rectal surgery in patients with locally advanced rectal adenocarcinoma: a propensity score matching study
por: Huang, Ching-Wen, et al.
Publicado: (2020)

UGT1A1 Polymorphism for Irinotecan Dose Escalation in Patients with BRAF-Mutated Metastatic Colorectal Cancer Treated with First-Line Bevacizumab and FOLFIRI
por: Hsieh, Yi-Chien, et al.
Publicado: (2021)

Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer
por: Song, Ji Hyeong, et al.
Publicado: (2023)

Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study
por: Wang, Jianping, et al.
Publicado: (2020)

Combining methylated SDC2 test in stool DNA, fecal immunochemical test, and tumor markers improves early detection of colorectal neoplasms
por: Zeng, Tao, et al.
Publicado: (2023)

Pretreatment Neutrophil-to-Lymphocyte Ratio Associated with Tumor Recurrence and Survival in Patients Achieving a Pathological Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer
por: Huang, Chun-Ming, et al.
Publicado: (2021)

The clinicopathological significance of NAB2‐STAT6 gene fusions in 52 cases of intrathoracic solitary fibrous tumors
por: Huang, Shih‐Chiang, et al.
Publicado: (2015)

Feasibility of robot-assisted surgery in elderly patients with rectal cancer
por: Su, Wei-Chih, et al.
Publicado: (2021)

BRAF, MEK, and EGFR Triplet Inhibitors as Salvage Therapy in BRAF-Mutated Metastatic Colorectal Cancer—A Case Series Study Target Therapy of BRAF-Mutated mCRC
por: Yeh, Jen-Hao, et al.
Publicado: (2021)

Role of non-coding RNAs in radiosensitivity of colorectal cancer: A narrative review
por: Huang, Chun-Ming, et al.
Publicado: (2022)

Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy
por: Yin, Tzu-Chieh, et al.
Publicado: (2023)

Supercollider: SDC for SSC
Publicado: (1992)

The SDC trigger system
por: Smith, W H
Publicado: (1992)

Clinicopathological Features and Oncological Outcomes of Early and Late Recurrence in Stage III Colorectal Cancer Patients after Adjuvant Oxaliplatin-Based Therapy
por: Chang, Yu-Tang, et al.
Publicado: (2023)

Efficacy of transarterial chemoembolization with drug-eluting beads combined with systemic chemotherapy and targeted therapy in colorectal cancer liver metastasis
por: Chen, Yen-Cheng, et al.
Publicado: (2023)

Comparison of UGT1A1 Polymorphism as Guidance of Irinotecan Dose Escalation in RAS Wild-Type Metastatic Colorectal Cancer Patients Treated With Cetuximab or Bevacizumab Plus FOLFIRI as the First-Line Therapy
por: Tsai, Hsiang-Lin, et al.
Publicado: (2022)

Irinotecan dose reduction in metastatic colorectal cancer patients with homozygous UGT1A1*28 polymorphism: a single-center case series
por: Tsai, Hsiang-Lin, et al.
Publicado: (2022)

Prognostic impact of extratumoral perineural invasion in patients with oral cavity squamous cell carcinoma
por: Lee, Li‐Yu, et al.
Publicado: (2019)

Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer: Where Are We at?
por: Yeh, Jen-Hao, et al.
Publicado: (2022)

Critical reappraisal of neoadjuvant concurrent chemoradiotherapy for treatment of locally advanced colon cancer
por: Chen, Yen-Cheng, et al.
Publicado: (2021)

miRNA-148a Enhances the Treatment Response of Patients with Rectal Cancer to Chemoradiation and Promotes Apoptosis by Directly Targeting c-Met
por: Huang, Chun-Ming, et al.
Publicado: (2021)

Comparison of Next-Generation Sequencing and Polymerase Chain Reaction for Personalized Treatment-Related Genomic Status in Patients with Metastatic Colorectal Cancer
por: Su, Wei-Chih, et al.
Publicado: (2022)

Extended-Release Dinalbuphine Sebacate Versus Intravenous Patient-Controlled Analgesia with Fentanyl for Postoperative Moderate-to-Severe Pain: A Randomized Controlled Trial
por: Chang, Tsung-Kun, et al.
Publicado: (2020)

Surgical Efficacy and Safety of Patients with Locally Advanced Gastric Cancer following Neoadjuvant Concurrent Chemoradiotherapy and Chemotherapy
por: Li, Ching-Chun, et al.
Publicado: (2022)

MicroRNA-148a induces apoptosis and prevents angiogenesis with bevacizumab in colon cancer through direct inhibition of ROCK1/c-Met via HIF-1α under hypoxia
por: Tsai, Hsiang-Lin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pna5mpkb0d8v8nivrvkitf4ot5